http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-581393-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e981cb459b5dfdea22bb3d467aac14d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8261 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8279 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53 |
| filingDate | 2002-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f6a875c97d16a3a7a6998cbbae98743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1c0c4f60d11226071306fe687b52561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f012b16f36cc208c8ad0b684271d871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b8c30b7b61d85a661da13ae91490ee |
| publicationDate | 2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-581393-A |
| titleOfInvention | Manipulation of flavonoid biosynthesis in plants (6) and isolated nucleic acids encoding flavanone 3-hydroxylase (F3H) |
| abstract | Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding F3H, or complementary or antisense to a sequence encoding F3H, said nucleic acid or nucleic acid sequence including a nucleotide sequence selected from the group consisting of (a) sequences shown in Figure 73 hereto (Sequence ID No: 202); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) or (c), wherein said functionally active fragment or variant has a sequence having at least 80% identity to the sequence upon which the fragment or variant is based and has a size of at least 20 nucleotides. Further disclosed is a substantially purified or isolated F3H polypeptide, wherein said polypeptide includes an amino acid sequence selected from the group consisting of (a) sequences shown in Figure 74 hereto (Sequence ID No: 203); and (b) functionally active fragments and variants of the sequences shown in (a), wherein said functionally active fragment or variant has a sequence having at least 90% identity to a sequence recited in (a). |
| priorityDate | 2001-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 197.